Lung cancer treatment breakthroughs give hope and the chance for patients to appreciate the “Little Things” their lungs do for them

November is lung cancer awareness month

Wednesday, November 9, 2016 — Los Angeles, CA - Blowing out candles on a birthday cake, cheering a favorite sports team’s winning play, or inhaling the sweet aroma of a fresh baked pumpkin pie are just a few examples of the little things lung cancer patients and survivors are thankful for this November during Lung Cancer Awareness Month.

Lung Cancer Foundation of America (LCFA) wants everyone to remember that - “Life should take your breath away, not lung cancer.” Lung cancer strikes smokers, non-smokers, men, women, all races and all ages.

In honor of lung cancer awareness month, LCFA is launching the “Little Things” campaign #littlethingsLCFA and urging people to share on social media how grateful they are for the little things their lungs allow them to do. People can help LCFA fund life-saving research by joining the “Little Things” campaign, posting to Facebook, Twitter and Instagram, and learning more at lcfamerica.org.

Lung cancer is the leading cause of cancer death among ALL Americans, killing twice as many women as breast cancer. There is a misconception about lung cancer that there isn’t much hope following a diagnosis. New patients need to know they should ask for genomic testing to identify their tumor type. Depending on the type of tumor, there are a number of treatment options.

New treatments for patients include using targeted therapy to treat more than a dozen types of lung cancer tumors. In addition, immunotherapy helps your immune system attack and kill cancer cells, effectively exposing cancer cells so your body can destroy them. Lung cancer patients should also investigate whether they are eligible for treatment through groundbreaking clinical trials.

“We are on the precipice of exciting new advancements in treating lung cancer. In the past two years, the Food and Drug Administration (FDA) approved twice as many new therapies for lung cancer patients than in the last ten years! But this momentum can only continue with funding for research. Lung cancer research is still severely underfunded, especially considering it kills more than breast, colon and prostate cancer combined,” says Kim Norris, LCFA President and Co-Founder.

Little Things LCFA (short)